The tumor necrotic effects of bacterial lipopolysaccharides (LPS) have been known for several decades (2, 23) . Recent findings by Carswell et al. showed that this tumor necrosis activity is mediated by a factor found in sera of LPStreated tumor-bearing animals (1) . This factor was also found in sera of BCG-infected mice hours after LPS injection (BCG-LPS serum) (1) . That the serum factor also has cytotoxic activity against tumor cells in vitro (but not against normal embryo cells) provides a relatively simple and quantitative assay (1, 5, 8, 12, 20) .
We have previously shown that a cytotoxic factor (CF) physicochemically similar to that found in BCG-LPS sera can be detected in cultures of LPS-treated macrophages from BCGinfected mice (9, 10) . This observation suggested that CF may contribute to the cytotoxic activity of activated macrophages (9) .
We have explored this possibility in this report by using the immunoglobulin G (IgG) fraction from a rabbit antiserum raised against serumderived CF to define a possible role for this molecule in nonspecific macrophage-mediated tumor cytotoxicity.
MATERIALS AND METHODS Mice. Male and female C3H/HeN and C57BL/6N mice, 6 Lymphokine supernatant. C3H/HeN mice were immunized intradermally with 5 x 106 viable Mycobacterium bovis, strain BCG (Phipps substrain, TMC 1029, Trudeau Mycobacterial Collection, Saranac Lake, N.Y.) (22) . Animals were sacrificed 3 to 6 weeks after BCG immunization. Spleens were aseptically removed and passed through no. 50 mesh stainless-steel sieves into tissue culture medium (RPMI 1640 with antibiotics; GIBCO Laboratories, Grand Island, N.Y.). Single-cell suspensions, obtained by serial aspirations through 19 -and 23-gauge needles, were treated with tris(hydroxymethyl)aminomethane-buffered NH4Cl solution to lyse erythrocytes. Spleen cells were centrifuged at 250 x g for 10 min at 4°C and suspended to a concentration of 5 x 106 viable cells/ml in medium with 5% heat-inactivated fetal calf serum (GIBCO).
Twenty-milliliter portions of the spleen cell suspension with 50 
RESULTS
Correlation between macrophage tumoricidal activity and release of CF. A soluble CF physicochemically similar to that found in BCG-LPS sera is detected in culture fluids of LPS-treated macrophages from BCG-infected animals (9, 10) . To determine whether CF plays a role in the nonspecific tumoricidal activity of activated macrophages in vitro, we attempted to correlate levels ofmacrophage tumoricidal activity with release of CF into culture fluids (Table  1 ). Macrophages from mice treated i.p. with viable BCG, killed C. parvum, or pyran copolymer were strongly cytotoxic to tumor cells in vitro; cells from mice treated with PBS, starch, or latex beads had little or no cytotoxic activity. Levels of CF released by any of these cytotoxic or noncytotoxic macrophages, however, were negligible. These observations confirm those in many previous reports which failed to detect soluble cytotoxins in cultures of activated macrophages (see reference 6 for review).
The pattern of CF release by macrophage cultures incubated with small amounts of LPS, however, was entirely different from that described above. Cultures of activated macrophages from three different sources (BCG-, C.
VOL. 33, 1981 parvum-, or pyran-treated mice) incubated with 10 ng of LPS per ml released significant levels of CF. LPS alone (data not shown) or culture fluids from LPS-treated inflammatory macrophages had little or no cytotoxic activity (Table 1) . Even though detectable levels of CF were evident only in culture fluids of activated macrophages treated with an extraordinary stimulus such as LPS, CF could still contribute to the cytotoxic effects of these cells in the absence of LPS. For example, CF bound to macrophages or released only in the macrophage-tumor cell microenvironment would not be detected in culture fluids. To examine this alternative, we attempted to inhibit CF activity with a partially purified and specific rabbit antiserum.
Inhibition of the cytotoxic activity in BCG-LPS sera by rabbit antiserum against serum-derived CF. CF in sera of BCG-infected mice treated intravenously with LPS was partially purified by ammonium sulfate precipitation, diethylaminoethyl ion exchange, and Sephacryl S200 chromatography as previously described (8) . Sera of normal mice treated with LPS (control sera) were fractionated by an identical protocol. Rabbits were immunized with purified CF or control sera and bled periodically. The ammonium sulfate precipitate of serum from rabbits immunized with CF inhibited the cytotoxic activity in BCG-LPS sera: 50% inhibition was evident at a 1:640 dilution of antiserum; inhibition was complete at 1:160 (Fig. 1) . In contrast, control serum even at the highest concentration (1:40) effected only a slight inhibition of cytotoxic activity.
The inhibitory activity of rabbit anti-CF was isolated in the IgG fraction ( rose columns were exposed to equal concentrations of IgG from anti-CF and control sera. When BCG-LPS serum was passed over the anti-CF column, all cytotoxic activity was retained. In contrast, the titer of cytotoxic activity in BCG-LPS serum was unchanged after passage over the control serum column (Table 3) .
Effect of rabbit anti-CF on the tumoricidal activity of activated macrophages. Macrophages activated in vivo by the effects of BCG infection or activated in vitro by lymphokines were cultured with tumor target cells in the presence of IgG from sera of immunized (anti-CF), control (control sera), and untreated rabbits (Fig. 2) . Anti-CF exerted a significant inhibitory effect on macrophage-mediated cytotoxicity with both BCG-and lymphokine-activated cells. Inhibition was most evident at the lower effector/target cell ratios. IgG from sera of untreated rabbits had no effect on macrophage tumoricidal activity. In contrast, IgG from sera of control rabbits (animals immunized with sera from normal mice injected with LPS) actually enhanced tumor cytotoxicity. Since both target cells and mouse serum were of C3H/HeN origin, enhancing activity in control serum could have been mediated by rabbit anti-C3H/HeN antibodies not present in sera of untreated rabbits. In fact, absorption of all rabbit sera with 1023 target cells reduced this enhancement without affecting the inhibitory effects of anti-CF (Fig.   3 ).
The inhibitory effects of anti-CF on tumor cytotoxicity by activated macrophages was independent of mouse strain and activation stimulus (Table 4) . Effects of anti-CF were, however, dependent upon the effector/target cell ratio and the amount of anti-CF added during the cytotoxicity assay. Inhibition of macrophage tumoricidal activity was not evident at effector/ target cell ratios greater than or equal to 15:1 to 20:1 or with less than 0.25 ,ug of anti-CF IgG per ml (data not shown). This latter effect was not due to loss by absorption or destruction of antibody activity during the 48-h cytotoxicity assay. ;4 <To test this possibility, we examined effects of anti-CF on tumor cytotoxicity by BCG-activated macrophages cultured with and without LPS for 2 h. All cultures were then washed and incubated with anti-CF and target cells (Fig. 4) . Anti-CF inhibited the cytotoxic activity of both LPStreated and nontreated BCG-activated macro-IG phages. The degrees of inhibition were comparable.
It is important to note that the measurement of macrophage-mediated tumor cytotoxicity by release of [3H]TdR used in these studies underestimates the extent of macrophage-tumor cell interaction. Macrophage-mediated cytostatic effects are not measured by this assay. Moreover, (Mannel, unpublished data) . CF may be stored within the macrophage and secreted or exposed on the cell membrane only after LPS treatment or perhaps after tumor cell contact.
Complete or near complete inhibition of macrophage cytotoxic activity by anti-CF was evident only at low effector/target cell ratios. At ratios greater or equal to 15:1 to 20:1, macrophage tumoricidal activity was unaffected even by the highest concentration of antibody. Inhibition was not complete at any level of cytotoxicity (range, 33 to 89%) but was consistent in all experiments. Cinemicrographic and microscopic studies of activated macrophages and tumor cells show that tumor cell destruction involves close contact between effector and target cells (11, 14) . In fact, recent studies suggest that binding of tumor cells to macrophages may be a prerequisite event for cytolysis (11) . One could assume that the failure to detect anti-CF inhibition at high macrophage/tumor cell ratios reflects steric exclusion of the antibody from the presumed site of killing, the area of contact between macrophage and tumor cell. Alternatively, cytotoxic mechanisms of nonspecifically activated macrophages may vary with the microenvironment. CF may play a major role in cytotoxicity at low cell densities, a hypothesis consistent with the inhibitory effects of anti-CF. Cytotoxicity at higher cell densities, however, might be mediated by multiple and overlapping mechanisms so that elimination of CF-mediated events would be compensated.
In any event, the data presented in this report strongly implicate CF as at least one of the effector molecules in activated macrophage-mediated tumor cytotoxicity. The interesting findings by Kull and Cuatrecasas that CF must be internalized by the target cell to obtain cytolysis (C. F. Kull, Jr., and P. Cuatrecasas, Fed. Proc. 39: 478, 1980) and the observations in this paper suggest a series of future experiments that could clarify the mechanisms of macrophage tumoricidal activity.
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